MedPath

Phase III Randomized Study of Oral Acyclovir in Infants With Herpes Simplex Virus Infection Limited to Skin, Eyes, and Mouth

Phase 3
Completed
Conditions
Herpes Simplex
Registration Number
NCT00006135
Lead Sponsor
National Center for Research Resources (NCRR)
Brief Summary

OBJECTIVES:

I. Determine the efficacy of long term suppressive therapy with oral acyclovir in infants with herpes simplex virus infection limited to skin, eyes, and mouth.

II. Determine the neurologic outcome in these patients when treated with this regimen.

III. Evaluate the significance of a positive cerebrospinal fluid (CSF) polymerase chain reaction (PCR) result when all other CSF parameters remain normal in these patients.

IV. Correlate the time to first positive CSF PCR result in the first 12 months of life with clinical neurological assessment in these patients when treated with this regimen.

V. Determine whether the continuous administration of this drug suppresses recurrent skin lesions in these patients.

VI. Determine the safety of this regimen in these patients.

Detailed Description

PROTOCOL OUTLINE:

This is a randomized, double blind, placebo controlled, multicenter study.

All patients undergo a lumbar puncture and then receive acyclovir IV every 8 hours on Days 1-14. On Day 12, patients may undergo a lumbar puncture (at discretion of investigator). Whole blood is obtained for herpes simplex virus PCR analysis. Upon completion of intravenous therapy, patients with a negative CSF PCR are randomized to one of two treatment arms.

Arm I: Patients receive oral acyclovir three times daily for 6 months.

Arm II: Patients receive placebo three times daily for 6 months.

In case of cutaneous recurrence during the first 12 months of the study, patients receive open label oral acyclovir (if CSF PCR is negative) or acyclovir IV (if CSF PCR is positive) for 5 days. Patients may or may not continue on study drug following this treatment.

Patients are followed at 6, 12, 24, 36, 48, and 60 months of age.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
66
Inclusion Criteria

Not provided

Read More
Exclusion Criteria

Not provided

Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (27)

University of Texas Southwestern Medical School

πŸ‡ΊπŸ‡Έ

Dallas, Texas, United States

Cedars-Sinai Medical Center

πŸ‡ΊπŸ‡Έ

Los Angeles, California, United States

Tulane University Medical Center

πŸ‡ΊπŸ‡Έ

New Orleans, Louisiana, United States

Maine Medical Center

πŸ‡ΊπŸ‡Έ

Portland, Maine, United States

University of Arkansas

πŸ‡ΊπŸ‡Έ

Little Rock, Arkansas, United States

Medical University of South Carolina

πŸ‡ΊπŸ‡Έ

Charleston, South Carolina, United States

University of Arkansas for Medical Sciences

πŸ‡ΊπŸ‡Έ

Little Rock, Arkansas, United States

Ohio State University Children's Hospital

πŸ‡ΊπŸ‡Έ

Columbus, Ohio, United States

University of Florida Health Science Center - Jacksonville

πŸ‡ΊπŸ‡Έ

Jacksonville, Florida, United States

University of Manitoba-Winnipeg

πŸ‡¨πŸ‡¦

Winnipeg, Manitoba, Canada

University of Alberta

πŸ‡¨πŸ‡¦

Edmonton, Alberta, Canada

Children's Hospital of Alabama

πŸ‡ΊπŸ‡Έ

Birmingham, Alabama, United States

University of Alabama Comprehensive Cancer Center

πŸ‡ΊπŸ‡Έ

Birmingham, Alabama, United States

Children's Hospital and Health Center

πŸ‡ΊπŸ‡Έ

San Diego, California, United States

Children's Hospital Medical Center - Cincinnati

πŸ‡ΊπŸ‡Έ

Cincinnati, Ohio, United States

University of Texas Health Science Center at San Antonio

πŸ‡ΊπŸ‡Έ

San Antonio, Texas, United States

Vanderbilt University

πŸ‡ΊπŸ‡Έ

Nashville, Tennessee, United States

Baylor College of Medicine

πŸ‡ΊπŸ‡Έ

Houston, Texas, United States

MetroHealth Medical Center

πŸ‡ΊπŸ‡Έ

Cleveland, Ohio, United States

Cook Children's Medical Center - Fort Worth

πŸ‡ΊπŸ‡Έ

Fort Worth, Texas, United States

University of Tennessee Medical Center at Knoxville

πŸ‡ΊπŸ‡Έ

Knoxville, Tennessee, United States

State University of New York - Upstate Medical University

πŸ‡ΊπŸ‡Έ

Syracuse, New York, United States

Stanford University

πŸ‡ΊπŸ‡Έ

Stanford, California, United States

University of Mississippi Medical Center

πŸ‡ΊπŸ‡Έ

Jackson, Mississippi, United States

Carolinas Medical Center

πŸ‡ΊπŸ‡Έ

Charlotte, North Carolina, United States

St. Louis Children's Hospital

πŸ‡ΊπŸ‡Έ

Saint Louis, Missouri, United States

Rhode Island Hospital

πŸ‡ΊπŸ‡Έ

Providence, Rhode Island, United States

Β© Copyright 2025. All Rights Reserved by MedPath